Mechanism of serum-mediated endothelial injury in scleroderma: Identification of a granular enzyme in scleroderma skin and sera

Clinical Immunology and Immunopathology

Volumn 83, Issue 1, 1997, Pages 32-40

  Bashar Kahaleh, M ^a   Fan, Pan Sheng ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GRANZYME A; GROWTH INHIBITOR; INTERLEUKIN 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; ENDOTHELIUM INJURY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LYMPHOCYTE; MALE; PRIORITY JOURNAL; SCLERODERMA; SERUM; SKIN BIOPSY;

EID: 0031127473     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.4322     Document Type: Article

References (38)

1. 1. Norton, W. L., and Nardo, J. M., Vascular disease in progressive systemic sclerosis (scleroderma). Ann. Intern. Med. 73, 317, 1970.
2. 2. Fleishmajer, R., Perlish, J. S., and Reeves, R. T., Cellular infiltrates in scleroderma skin. Arthritis Rheum. 20, 975-982, 1977.
3. 3. Kahaleh, M. B., Sherer, G. K., and LeRoy, E. C., Endothelial injury in scleroderma. J. Exp. Med. 149, 1326-1335, 1979.
4. 4. Kahaleh, M. B., and LeRoy, E. C., Endothelial injury in scleroderma: A protease mechanism. J. Lab. Clin. Med. 101, 553-560, 1983.
5. + lymphocytes. Eur. J. Immunol. 17, 1625-1633, 1987.
6. 6. Jaffe, E. A., Nachman, R. L., Becker, C.G., and Minick, C. R., Culture of human endothelial cells derived from umbilical veins: Identification by morphological and immunological criteria. J. Clin. Invest. 52, 2745-2756, 1973.
7. 7. Pastternak, M. S., and Eisen, H. N., A novel serine esterase expressed by cytotoxic T lymphocytes. Nature (London) 314, 743, 1985.
8. 8. Gershom, J. M., Davis, F. E., and Palade, G. E., Protein blotting in uniform or gradient electric fields. Anal. Biochem. 144, 32-40, 1985.
9. 9. Chomczynski, P., and Sacchi, N., Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159, 1987.
10. 10. Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., Mullis, K. B., and Erlich, H. A., Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239, 487-491, 1988.
11. 11. Gershenfeld, H. K., and Weissman, I. L., Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science 232, 854-858, 1986.
12. 12. Klein, J. L., Shows, T. B., Dupont, B., and Trapani, J. A., Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes. Genomics 5, 110-117, 1989.
13. 13. Nakajima, H., and Henkart, P.A., Cytotoxic lymphocyte granzymes trigger a target cell internal disintegration pathway leading to cytolysis and DNA breakdown. J. Immunol. 152(3), 1057-1063, 1994.
14. 14. Prescott, R. J., Freemont, A. J., Jones, C. J. P., Hoyland, J., and Fielding, P., Sequential dermal microvascular and perivascular changes in the development of scleroderma. J. Pathol. 166, 255-263, 1992.
15. 15. Scharffetter, K., Lankat-Buttgereit, B., and Krieg, T., Localization of collagen mRNA in normal and scleroderma skin by in situ hybridization. Eur. J. Clin. Invest. 18, 9-17, 1988.
16. 16. Fleischmajer, R., Perlish, J. S., and West, W. P., Ultrastructure of cutaneous cellular infiltrates in scleroderma. Arch. Dermatol. 113, 1661-1466, 1977.
17. 17. Fleischmajer, R., and Perlish, J. S., Capillary alterations in scleroderma. J. Am. Acad. Dermatol. 2, 161-170, 1983.
18. 18. Cohen, S., Johnson, A. R., and Hurd, E., Cytotoxicity of sera from patients with scleroderma. Arthritis Rheum. 26, 170-178, 1983.
19. 19. Meyer, O., Haim, T., and Dryll, A., Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases. Clin. Exp. Rheumatol. 1, 29-34, 1983.
20. 20. Drenk, F., and Deicher, H. R. G., Pathophysiological effects of endothelial cytotoxic activity derived from sera of patients with progressive systemic sclerosis. J. Rheumatol. 15, 468-474, 1988.
21. 21. Shanahan, W. R., Jr., and Korn, J. H., Cytotoxic activity of sera from scleroderma and other connective tissue diseases: Lack of cellular and disease specificity. Arthritis Rheum. 25, 1391-1395, 1982.
22. 22. Blann, A. D., Illingworth, K., and Jayson, M. I. V., Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J. Rheumatol. 20, 1325-1330, 1993.
23. 23. Kahaleh, B., Immunologic aspects of scleroderma. Curr. Opin. Rheumatol. 5, 760-765, 1993.
24. 24. Damle, N. K., and Doyle, L. V., IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. J. Immunol. 142(8), 2660-2669, 1989.
25. 25. Damle, N. K., Doyle, L. V., Bender, J. R., and Bradley, E. C., Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J. Immunol. 138(6), 1779-1785, 1987.
26. 26. Kotasek, D. G., Vercellotti, M., Ochoa, A. C., Bach, F. H., White, J. G., and Jacob, H. S., Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells. Cancer Res. 48, 5528-5532, 1988.
27. 27. Hameed, A. D., Lowrey, M., Lichtenheld, M., and Podack, E. R., Characterization of three serine proteases isolated from human IL-2 activated killer cells. J. Immunol. 141, 3142-3147, 1988.
28. 28. Masson, D., and Tschopp, J., Inhibition of lymphocyte protease granzyme A by antithrombin III. Mol. Immunol. 35(12), 1283-1289, 1988.
29. 29. Nakamura, K., Arahata, K., Ishiura, S., Osame, M., and Sugita, H., Degradative activity of granzyme A on skeletal muscle proteins in vitro: A possible molecular mechanism for muscle fiber damage in polymyositis. Neuromuscular Disord. 3(4), 303-310, 1993.
30. 30. Griffiths, G. M., Alpert, S., Lambert, E., McGuire, J., and Weissman, I. L., Perforin and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 89(2), 549-553, 1992.
31. 31. Tsubota, K., Saito, I., and Miyasaka, N., Expression of granzyme A and perform in lacrimal gland of Sjogren's syndrome. Adv. Exp. Med. Biol. 350, 637-640, 1994.
32. 32. Alpert, S., Kang, H. I., Weissman, I., and Fox, R. I., Expression of granzyme A in salivary gland biopsies from patients with primary Sjogren's syndrome. Arthritis Rheum. 37(7), 1046-1054, 1994.
33. 33. Jenne, D. E., and Tschopp, J., Granzymes: A family of serine proteases in granules of cytolytic T lymphocytes. Curr. Top. Microbiol. Immunol. 140, 33-47, 1988.
34. 34. Masson, D., Corthesy, P., Nabholz, M., and Tschopp, J., Appearance of cytolytic granules upon induction of cytolytic activity in CTL-hybrids. EMBO J. 4, 2533-2538, 1985.
35. 35. Leroy, E. C., Black, C., Fleischmajer, R., Joblonska, S., Kreig, T., Medsger, T. A., Rowell, N., and Wollheim, F., Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J. Rheumatol. 15, 202-205, 1988.
36. 36. Masson, D., and Tschopp, J., A family of serine esterases in lytic granules of cytolytic lymphocytes. Cell 49, 679-685, 1987.
37. 37. Suidan, H. S., Bouvier, J., Schaerer, E., Stone, S. R., Monard, D., and Tschopp, J., Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc. Natl. Acad. Sci. 91, 8112-8116, 1994.
38. 38. MacDermott, R. P., Schmidt, R. E., Caulfield, J. P., Hein, A., Bartley, G. T., Ritz, J., Schlossman, S. F., Austen, K. F., and Steven, R. L., Proteoglycans in cell-mediated cytotoxicity: Identification, localization, and exocytosis of a chondroitin sulfate proteoglycan from human cloned natural killer cells during target cell lysis. J. Exp. Med. 162, 1771-1767, 1985.